Johnson & Johnson buy matumba
Summary
This prediction ended on 18.09.14 with a price of €82.61. The BUY prediction by matumba finished with a performance of 6.74%. matumba has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | 0.956% | 0.956% | -1.421% | 5.442% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by matumba for this prediction
In the thread Johnson & Johnson diskutieren
nicht nur bei dividenden ein renner..
Diese Titel überzeugen Investoren offenbar mit ihren guten Geschäftsperspektiven und sollten daher die Klettertour fortsetzen,
Stopped prediction by matumba for Johnson & Johnson
Johnson & Johnson
01.11.19
04.11.21
05.11.21
Johnson & Johnson
22.02.14
04.07.14
04.07.14
Johnson & Johnson
07.04.12
05.07.12
05.07.12